Atlas FDA

Abbott Clinical Chemistry Creatine Kinase, Model LN 7D63-30, Lot Number: 52044HW00; Expires October 19, 2007, RCR#201843

FDA device recall Z-1109-2008 · posted 2008-03-19 · Terminated

Recall details

Recalling firm
Abbott Laboratories Inc.
Reason for recall
Three potential issues with Creatine Kinase Lot Number: 52044HW00: (1) Decrease in quality control and/or patient results (2) An iIncreased imprecision, or (3) Error Code 1054 (Unable to calculate results, Reaction Failure) on Architect cSystems.
Action taken
On October 12, 2007, A Product Recall letter was provided to all Clinical Chemistry Creatine Kinase Reagent customers that have received lot number 52044HW00 . Customer reply form were included in all US customers letter. The letter instructed customers to discontinue use of the kits and destroy them following their laboratory procedure, and document the number of kits discarded. Abbott will provide reimbursement for destroyed kits.
Root cause
Nonconforming Material/Component
Status
Terminated
Product code
CGS
Quantity affected
334 Distributed Worldwide; 164 Domestically
Distribution
Worldwide Distribution --- including USA and countries of Canada, Chili, Uruguay, Germany, Hong Kong, and New Zealand.
Date initiated
2007-10-12
Date posted
2008-03-19
Date terminated
2012-03-28
Location
South Pasadena, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
CK (K983070)Abbott Laboratories1999-02-16